ARCT
Price
$9.48
Change
-$0.72 (-7.06%)
Updated
Apr 3 closing price
Capitalization
257.23M
38 days until earnings call
BNTX
Price
$92.01
Change
-$1.31 (-1.40%)
Updated
Apr 3 closing price
Capitalization
22.39B
31 days until earnings call
Ad is loading...

ARCT vs BNTX

Header iconARCT vs BNTX Comparison
Open Charts ARCT vs BNTXBanner chart's image
Arcturus Therapeutics Holdings
Price$9.48
Change-$0.72 (-7.06%)
Volume$362.42K
Capitalization257.23M
BioNTech SE American Depositary Share
Price$92.01
Change-$1.31 (-1.40%)
Volume$937.22K
Capitalization22.39B
ARCT vs BNTX Comparison Chart
Loading...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARCT vs. BNTX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARCT is a Hold and BNTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ARCT: $9.48 vs. BNTX: $92.01)
Brand notoriety: ARCT and BNTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARCT: 83% vs. BNTX: 108%
Market capitalization -- ARCT: $257.23M vs. BNTX: $22.39B
ARCT [@Biotechnology] is valued at $257.23M. BNTX’s [@Biotechnology] market capitalization is $22.39B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARCT’s FA Score shows that 0 FA rating(s) are green whileBNTX’s FA Score has 2 green FA rating(s).

  • ARCT’s FA Score: 0 green, 5 red.
  • BNTX’s FA Score: 2 green, 3 red.
According to our system of comparison, BNTX is a better buy in the long-term than ARCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARCT’s TA Score shows that 4 TA indicator(s) are bullish while BNTX’s TA Score has 4 bullish TA indicator(s).

  • ARCT’s TA Score: 4 bullish, 4 bearish.
  • BNTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, BNTX is a better buy in the short-term than ARCT.

Price Growth

ARCT (@Biotechnology) experienced а -20.96% price change this week, while BNTX (@Biotechnology) price change was -3.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

ARCT is expected to report earnings on May 12, 2025.

BNTX is expected to report earnings on May 05, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNTX($22.4B) has a higher market cap than ARCT($257M). BNTX YTD gains are higher at: -19.254 vs. ARCT (-44.107). ARCT has higher annual earnings (EBITDA): -77.4M vs. BNTX (-367.1M). BNTX has more cash in the bank: 16.8B vs. ARCT (237M). ARCT has less debt than BNTX: ARCT (28.6M) vs BNTX (254M). BNTX has higher revenues than ARCT: BNTX (2.75B) vs ARCT (138M).
ARCTBNTXARCT / BNTX
Capitalization257M22.4B1%
EBITDA-77.4M-367.1M21%
Gain YTD-44.107-19.254229%
P/E RatioN/A161.76-
Revenue138M2.75B5%
Total Cash237M16.8B1%
Total Debt28.6M254M11%
FUNDAMENTALS RATINGS
ARCT: Fundamental Ratings
ARCT
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARCTBNTX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 18 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
78%
View a ticker or compare two or three
Ad is loading...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TILRX25.59N/A
N/A
Nuveen Large Cap Growth R
FIICX16.58N/A
N/A
Fidelity Advisor Mid Cap II C
GMXRX14.74N/A
N/A
Nationwide Mid Cap Market Idx R
SVXCX53.92N/A
N/A
Smead International Value C
PAHWX7.66N/A
N/A
PGIM Jennison Intl Sm-Md Cap Opps A

ARCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARCT has been loosely correlated with BMEA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ARCT jumps, then BMEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARCT
1D Price
Change %
ARCT100%
-7.01%
BMEA - ARCT
51%
Loosely correlated
-9.72%
AXON - ARCT
49%
Loosely correlated
-3.35%
ABCL - ARCT
47%
Loosely correlated
-5.86%
TRDA - ARCT
46%
Loosely correlated
-8.86%
BNTX - ARCT
42%
Loosely correlated
-1.40%
More

BNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with MRNA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then MRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
-1.40%
MRNA - BNTX
53%
Loosely correlated
-7.18%
TIL - BNTX
48%
Loosely correlated
-9.22%
CVAC - BNTX
45%
Loosely correlated
-0.70%
AXON - BNTX
43%
Loosely correlated
-3.35%
ARCT - BNTX
42%
Loosely correlated
-7.01%
More